inHEART Models vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by inHEART
VS
by Medtronic

AI Verdict

Tool A, inHEART Models, is designed for optimizing image-guided cardiac ablation procedures through AI-driven 3D digital twin models for pre-procedural planning. In contrast, Tool B, the Reveal LINQ Insertable Cardiac Monitor, is an implantable device focused on long-term, accurate heart rhythm monitoring and reducing false alerts with its AccuRhythm™ AI algorithms. While both fall under Cardiology AI, they serve distinct clinical purposes: one for interventional planning and the other for diagnostic surveillance.

Choose inHEART Models if…

Choose inHEART Models if your clinical focus is on optimizing the planning and execution of complex image-guided cardiac ablation procedures. This tool is ideal for electrophysiologists seeking highly detailed, AI-driven 3D digital twin models of the heart to enhance pre-procedural strategy and potentially reduce procedure times and recurrence rates for conditions like ventricular tachycardia.

View inHEART Models →

Choose Reveal LINQ if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous, and accurate monitoring for patients with suspected infrequent arrhythmias or unexplained syncope. This implantable device, with its AI-powered algorithms, is best suited for extended diagnostic surveillance to detect conditions like atrial fibrillation while minimizing false alerts, offering a discreet and durable solution for remote patient monitoring.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature inHEART Models Reveal LINQ
Pricing Contact for pricing Contact vendor
Deployment Cloud-based The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

inHEART Models

inHEART Models (Tool A) offers a cloud-based, interactive platform for clinicians to create and explore detailed 3D cardiac models, directly enhancing pre-procedural planning. Its seamless integration with major electroanatomic mapping systems suggests a user-friendly workflow for complex interventions. Reveal LINQ (Tool B), while easy for patients due to its passive nature, primarily involves clinicians reviewing transmitted data rather than direct interactive planning.

Clinical Value

inHEART Models

inHEART Models (Tool A) demonstrates strong clinical value by optimizing planning for cardiac ablation procedures, with a potential to reduce VT procedure times by 60% and recurrence rates by 38%. Reveal LINQ (Tool B) provides significant value in long-term diagnostic monitoring by reducing false alerts and enhancing diagnostic yield, but Tool A's direct impact on improving the efficiency and success of a critical intervention gives it an edge in this comparison.

Pricing & Value

Tie

Both inHEART Models (Tool A) and Reveal LINQ (Tool B) explicitly state that their pricing is not publicly disclosed and requires direct contact with the vendor. Without transparent pricing information for either product, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

Reveal LINQ

Reveal LINQ (Tool B), as a Medtronic product, benefits from the company's long-standing reputation and established infrastructure as a major medical device enterprise. It explicitly states HIPAA compliance and has a Business Associate Agreement (BAA) in place. While inHEART Models (Tool A) is FDA-cleared and SOC2 compliant, Medtronic's extensive experience and explicit compliance statements provide a slight advantage in terms of proven enterprise readiness and trust.

Innovation

inHEART Models

inHEART Models (Tool A) showcases greater innovation by introducing an AI-driven 'digital twin of the heart' for personalized, pre-procedural planning, fundamentally transforming how complex cardiac ablations are approached. Reveal LINQ (Tool B) innovates by refining an existing technology (ICM) with advanced AI for improved accuracy and battery life, which is valuable but represents an enhancement rather than a new paradigm in procedural guidance.

Support & Docs

Reveal LINQ

Medtronic (Tool B) provides extensive and publicly accessible support resources, including detailed documentation, patient and professional support lines, and training materials for its devices and the CareLink network. While inHEART (Tool A) undoubtedly offers customer support, the breadth and accessibility of its documentation and support infrastructure are not as readily apparent or comprehensive as those offered by a large, established medical device company like Medtronic.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature inHEART Models Reveal LINQ
Name inHEART Models Reveal LINQ Insertable Cardiac Monitor
Description AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures. The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Company inHEART Medtronic
Primary AI Application AI-driven digital twin of the heart; Automated segmentation of CT and MR images for 3D cardiac models. AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause) in continuous ECG monitoring.
Key Functionality Pre-procedural planning and optimization of treatment strategies for cardiac ablations, with integration with major electroanatomic mapping (EAM) systems. Continuous, long-term subcutaneous ECG monitoring with 4.5-year battery longevity and remote programming capabilities.
Specialties Cardiology, Radiology Cardiology, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring inHEART Models and Reveal LINQ.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

inHEART Models is an AI-driven software designed for pre-procedural planning and optimization of image-guided cardiac ablation procedures, particularly for ventricular tachycardia (VT). The Reveal LINQ Insertable Cardiac Monitor is an implantable device used for long-term, accurate heart monitoring to diagnose conditions like atrial fibrillation and syncope by detecting various cardiac arrhythmias.
inHEART Models utilizes AI to create detailed 3D digital twin models of the heart from CT/MR images, automating segmentation for precise pre-procedural planning. The Reveal LINQ ICM incorporates AccuRhythmu2122 AI algorithms to significantly reduce false alerts for conditions such as atrial fibrillation and pause, thereby enhancing diagnostic yield and accuracy in long-term ECG monitoring.
Both inHEART Models and the Reveal LINQ ICM are FDA-cleared medical devices. The Reveal LINQ ICM is explicitly stated to be HIPAA compliant and has a Business Associate Agreement (BAA). While not explicitly stated for inHEART Models, its SOC2 compliance and status as an FDA-cleared medical device handling patient data strongly suggest adherence to HIPAA regulations and BAA readiness.
inHEART Models offers seamless integration with major electroanatomic mapping (EAM) systems such as Cartou00ae, Rhythmiau2122, Ensiteu2122, and Afferau2122. The Reveal LINQ ICM transmits patient data to the cloud-based Medtronic CareLinku2122 network, which clinicians can access for remote monitoring and programming.
inHEART Models aims to potentially reduce VT procedure times by 60% and VT recurrence rates by 38% through optimized pre-procedural planning. The Reveal LINQ ICM focuses on enhancing diagnostic yield for conditions like atrial fibrillation and syncope by using AI to reduce false alerts, providing accurate long-term heart monitoring.
AI Tool Finder
AI-powered search. Results may not be comprehensive.